Apexian Pharmaceuticals, Inc. — Form D

Apexian Pharmaceuticals, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2016-02-16. The offering totals $750K, of which $750K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
John BarnardDirectorIndianapolis, IN
David BroeckerDirectorJeffersonville, IN
Martin Haslanger, PhDDirectorIndianapolis, IN
Mark Kelly, PhDDirectorIndianapolis, IN
Homer PearceDirectorIndianapolis, IN
David BroeckerExecutive OfficerJeffersonville, IN
Mark Kelly, PhDExecutive OfficerIndianapolis, IN
Roger MillerExecutive OfficerIndianapolis, IN
Steve CarchediDirectorCambridge, MA
Steve CarchediExecutive OfficerCambridge, MA
Timothy R TichenorExecutive OfficerIndianapolis, IN
John R BarnardDirectorIndianapolis, IN
Mark R Kelley, PhDDirectorIndianapolis, IN
Martin R Haslanger, PhDDirectorIndianapolis, IN
Roger R MillerExecutive OfficerIndianapolis, IN
David R BroeckerDirectorIndianapolis, IN
David R BroeckerExecutive OfficerIndianapolis, IN
Richard R MessmannExecutive OfficerIndianapolis, IN
Homer R Pearce, PhDDirectorIndianapolis, IN
Homer R PearceDirectorIndianapolis, IN
Mark R Kelly, PhDDirectorIndianapolis, IN
Mark R Kelly, PhDExecutive OfficerIndianapolis, IN
Timothy J TichenorExecutive OfficerGrand Rapids, MI
Richard R Messman, MDExecutive OfficerIndianapolis, IN
John H BarnardDirectorIndianapolis, IN

Other filings by this issuer (6)

FiledFormOfferingSold
2019-03-25D$2.0M$150K
2018-07-11D—$2.8M
2016-12-05D$1.5M$1.3M
2015-06-24D$650K$275K
2013-06-20D/A$2.5M$2.5M
2012-10-29D$2.0M$2.0M

More